Precision medicine: New biomarkers and targets beyond T2 inflammation
Chris Brightling (United Kingdom)
Source: ERS Lung Science Conference 2022
Number: 34
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Chris Brightling (United Kingdom). Precision medicine: New biomarkers and targets beyond T2 inflammation. ERS Lung Science Conference 2022
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|